571 related articles for article (PubMed ID: 27263022)
21. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
[TBL] [Abstract][Full Text] [Related]
22. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
[TBL] [Abstract][Full Text] [Related]
23. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
24. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
25. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
26. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541
[TBL] [Abstract][Full Text] [Related]
27. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
28. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
[TBL] [Abstract][Full Text] [Related]
29. The function of tissue transglutaminase in celiac disease.
Di Sabatino A; Vanoli A; Giuffrida P; Luinetti O; Solcia E; Corazza GR
Autoimmun Rev; 2012 Aug; 11(10):746-53. PubMed ID: 22326684
[TBL] [Abstract][Full Text] [Related]
30. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
[TBL] [Abstract][Full Text] [Related]
31. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
32. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.
Qiao SW; Piper J; Haraldsen G; Oynebråten I; Fleckenstein B; Molberg O; Khosla C; Sollid LM
J Immunol; 2005 Feb; 174(3):1657-63. PubMed ID: 15661929
[TBL] [Abstract][Full Text] [Related]
33. Exploring undiagnosed celiac disease in women with recurrent reproductive failure: The gluten-free diet could improve reproductive outcomes.
Alecsandru D; López-Palacios N; Castaño M; Aparicio P; García-Velasco JA; Núñez C
Am J Reprod Immunol; 2020 Feb; 83(2):e13209. PubMed ID: 31709662
[TBL] [Abstract][Full Text] [Related]
34. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
35. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767
[TBL] [Abstract][Full Text] [Related]
36. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
[TBL] [Abstract][Full Text] [Related]
37. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue.
Piper JL; Gray GM; Khosla C
Biochemistry; 2002 Jan; 41(1):386-93. PubMed ID: 11772038
[TBL] [Abstract][Full Text] [Related]
38. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten.
Moeller S; Canetta PA; Taylor AK; Arguelles-Grande C; Snyder H; Green PH; Kiryluk K; Alaedini A
PLoS One; 2014; 9(4):e94677. PubMed ID: 24732864
[TBL] [Abstract][Full Text] [Related]
39. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
[TBL] [Abstract][Full Text] [Related]
40. Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.
Lindstad CB; du Pré MF; Stamnaes J; Sollid LM
PLoS One; 2022; 17(4):e0266543. PubMed ID: 35385534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]